1. Home
  2. LSTA

LSTA

Lisata Therapeutics Inc.

Logo Lisata Therapeutics Inc.

Health Care

Misc Health and Biotechnology Services

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Founded: 1980 Country:
United States
United States
Employees: N/A City: BASKING RIDGE
Market Cap: 23.7M IPO Year: N/A
Target Price: $15.00 AVG Volume (30 days): 13.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.58 EPS Growth: N/A
52 Week Low/High: $1.95 - $4.53 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: